Secunderabad, India

Kumar Sarvesh

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kumar Sarvesh. Retrieved from https://idiyas.com/inventor/kumar-sarvesh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kumar Sarvesh

Introduction

Kumar Sarvesh is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of compounds used in cancer treatment. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Kumar Sarvesh's latest patents include a process for the preparation of eribulin and its intermediates. The first patent relates to a process for the preparation of a 4-Methylene tetrahydrofuran compound, which is useful as an intermediate for the preparation of halichondrin B analogues such as Eribulin. The second patent also focuses on the preparation of tetrahydrofuran and tetrahydropyran compounds, which serve as intermediates for the same purpose.

Career Highlights

Kumar Sarvesh is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at the company has allowed him to focus on innovative processes that enhance the development of important medicinal compounds.

Collaborations

Some of his coworkers include Debjit Basu and Sudhir Sai, who contribute to the collaborative environment at Dr. Reddy's Laboratories.

Conclusion

Kumar Sarvesh's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor in the industry. His work continues to impact the development of vital cancer treatment compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…